The effect of diethylnitrosamine on the levels of sialic acid, lipid-bound sialic acid and enzyme activities of transferase in rat serum

Turkish Journal of Veterinary and Animal Sciences

Volumn 29, Issue 3, 2005, Pages 607-612

  Şahin, Şeyda ^a   Türkmen, Gülhan ^a  

^a ISTANBUL UNIVERSITY   (Turkey)

Author keywords

Diethylnitrosamine; Lipid bound sialic acid; Liver enzymes; Rats; Sialic acid

Indexed keywords

EID: 22244478955     PISSN: 13000128     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Heidelberger, C.: Chemical carcinogesis. Ann. Rev. Biochem., 1975; 44: 79-121.
2. Enzmann, H., Brunnemann, K.D.: The in ovo carcinogenicity assay (IOCA): a review of an experimental approach for research on carcinogenesis and carcinogenecity testing. Front. Biosci., 1997; 2: 30-39.
3. Liao, D.J., Blanck, A., Eneroth, P., Gustafsson, J.A., Hällström, I.P.: Diethylnitrosamine causes pituitary damage, disturbs hormone levels, and reduces sexual dimorphism of certain liver functions in the rat. Environ. Health Perspect. 2001; 109: 943-947.
4. Akintonwa, D.A.: The derivation of nitrosamines from some therapeutic amines in the human environment. Ecotoxicol Environ. Saf., 1985; 9: 64-70.
5. Poirier, M.C., Beland, F.A.: DNA adducts measurements and tumor incidence during chronic carcinogen exposure in rodents. Environ. Health Perspect. 1994; 102: 161-165.
6. Dunsford, H.A., Karnasuta, C., Hunt, J.M., Sell, S.: Different lineages of chemically induced hepatocellular carcinoma in rat defined by monoclonal antibodies. Cancer Res., 1989; 49: 4894-4900
7. Goldsworthy, T.L., Hanigan, M.H.: Models of hepatocarcinogenesis in the rat contrasts and comparisons. CRC, Crit. Rev. Toxicol., 1986; 17: 61-89.
8. Solt, D.B., Medline, A., Farber, E.: Rapid emergence of carcinogen induced hyperplastic lesions in a new model for the sequential analysis of liver carcinogenesis. Am. J. Pathol., 1977; 88: 595-618.
9. Kang, C. B., Lee, E. S., Hur, J. H.: Effects of administration of CCl4 on liver function in rats. Serum enzyme activities. Korean J. Vet. Clin. Med., 1997; 14: 273-278.
10. Kang, C. B., Kim, C. H., Son, H. S.: Effects of administration of 2,2′-Azobis (2-amidinopropane) dihydrochloride (AAPH) on liver function in rats. 2. Serum enzyme activities. Korean J. Vet. Clin. Med. 1998; 15: 79-82.
11. Moore, M.R., Drinkwater, N.R., Miller, E.C., Miller, J.A., Pitot, H.C.: Quantitative analysis of the time-dependent development of glucose-6- phosphatase-deficient foci in the livers of mice treated neonatally with diethylnitrosamine. Cancer Res., 1981; 41: 1585-1593.
12. Bakir, S., Aker, A., Atalay, A.: Dietilnitrosamin'in glukoz-6 fosfat dehidrojenaz, hekzokinaz ve malat dehidrojenaz enzimlerine etkisi. Biyokimya Derg., 1989; 14: 7-12.
13. Chakraborty, A., Selvaraj, S.: Differential modulation of xenobiotic metabolising enzymes by vanadium during diethylnitrosamine induced hepatocarcinogenesis in Sprague-Dawley rats. Neoplasma, 2000; 47: 81-89.
14. Ha, W.S., Kim, C.K., Song, S.H., Kang, C.B.: Study on mechanism of multistep hepatotumorigenesis in rat: development of hepatotumorigenesis. J. Vet. Sci. 2001; 2: 53-58.
15. Giuliani, E.R., Zaki, F.G., Hall, J.C.: Serum and hepatic enzyme activity in rats treated with diethylnitrosamine. Toxicol. Pathol., 1983; 11: 23-27.
16. Özkurt, M.: Kanserojen madde verilmiş farelerin karaciǧer hücrelerindeki biyokimyasal deǧişiklikler. Gazi Üniv. Tip Fak. Biyokimya Anabilim Dali Uzm. Tezi. 1985.
17. Romppanen, J.: Serum sialic acid in clinical diagnostics. Medical Sciences. 2003; 309: 50 p.
18. Hammond, E. H.: Quality control and standardization for tumor markers. In: Diamandis EP, Fritsche, H.A., Lilja, H., Chan, D.W., Schwartz, M.K.: Tumor markers: Physiology, pathobiology, technology, and clinical applications. Washington, DC: AACC Press. 2002; 25-32.
19. Narayanan, S.: Sialic acid as a tumor marker. Ann. Clin. Lab. Sci., 1994; 24: 376-384.
20. O'Kennedy, R., Berns, G., Moran, E., Smyth, H., Carroll, K., Thornes, R.D., O'Brien, A., Fennely, J., Butler, M.: A critical analysis of the use of sialic acid determination in the diagnosis of malignancy. Cancer Lett., 1991; 58: 91-100.
21. Vedralova, E., Borovansky, J.: Evaluation of serum sialic acid fractions as markers for malignant melanoma. Cancer Lett., 1994; 78: 171-175.
22. Horgan, I.E.: Total and lipid-bound sialic acid levels in sera from patients with cancer. Clin. Chim. Acta., 1982; 118: 327-331.
23. Pönniö, M., Alho, H., Heinälä, P., Nikkari, S.T., Sillanaukee, P.: Serum and saliva levels of sialic acid are elevated in alcoholics. Alcohol Clin. Exp. Res., 1999; 23: 1060-1064.
24. Stefenelli, N., Klotz, H., Engel, A., Bauer, P.: Serum sialic acid in malignant tumors, bacterial infections, and chronic liver diseases. J. Cancer Res. Clin. Oncol., 1985; 109: 55-59.
25. Voigtmann, R., Pokorny, J., Meinshausen, A.: Evaluation and limitations of the lipid-associated sialic acid test for the detection of human cancer. Cancer, 1989; 64: 2279-2283.
26. Warren, L.: The thiobarbituric acid assay of sialic acids. J. Biol. Chem., 1972; 234: 1971-1975.
27. Simonsen, R., Uirji, M.A.: Interpreting the profile of liver-function tests in pediatric liver transplants. Clin. Chem., 1984; 30: 1607-1610.
28. Kim, K.S., Park, J.H.: Antihepatoxic effect of Artemisia Iwayomogi methanol extract on acute hepatic injury by carbon tetrachloride in rat. Korean J. Vet. Res., 1994; 34: 619-626.
29. Huseby, N.E., Ingebretsen, O.C.: The level of gamma-glutamyltransferase in serum, effect of carbohydrate heterogeneity on clearance rate. Scand. J. Clin. Lab. Invest., 1993; 215: 93-100.
30. Schutter, M.J., Visser, J.J., Kamp, G.J., Poully, S.M., Dijk, W., Hilgers, J., Kenemans, P.: The utility of lipid-associated sialic acid (LASA or LSA) as a serum marker for malignancy. Tumour Biol., 1992; 13: 121-132.